Correlation Between Entero Therapeutics, and Harmony Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Entero Therapeutics, and Harmony Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entero Therapeutics, and Harmony Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Entero Therapeutics, and Harmony Biosciences Holdings, you can compare the effects of market volatilities on Entero Therapeutics, and Harmony Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entero Therapeutics, with a short position of Harmony Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entero Therapeutics, and Harmony Biosciences.

Diversification Opportunities for Entero Therapeutics, and Harmony Biosciences

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Entero and Harmony is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Entero Therapeutics, and Harmony Biosciences Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Harmony Biosciences and Entero Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entero Therapeutics, are associated (or correlated) with Harmony Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Harmony Biosciences has no effect on the direction of Entero Therapeutics, i.e., Entero Therapeutics, and Harmony Biosciences go up and down completely randomly.

Pair Corralation between Entero Therapeutics, and Harmony Biosciences

Given the investment horizon of 90 days Entero Therapeutics, is expected to under-perform the Harmony Biosciences. In addition to that, Entero Therapeutics, is 1.09 times more volatile than Harmony Biosciences Holdings. It trades about -0.12 of its total potential returns per unit of risk. Harmony Biosciences Holdings is currently generating about 0.01 per unit of volatility. If you would invest  3,575  in Harmony Biosciences Holdings on August 27, 2024 and sell it today you would lose (104.00) from holding Harmony Biosciences Holdings or give up 2.91% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Entero Therapeutics,  vs.  Harmony Biosciences Holdings

 Performance 
       Timeline  
Entero Therapeutics, 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Entero Therapeutics, are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting basic indicators, Entero Therapeutics, displayed solid returns over the last few months and may actually be approaching a breakup point.
Harmony Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Harmony Biosciences Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong primary indicators, Harmony Biosciences is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Entero Therapeutics, and Harmony Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Entero Therapeutics, and Harmony Biosciences

The main advantage of trading using opposite Entero Therapeutics, and Harmony Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entero Therapeutics, position performs unexpectedly, Harmony Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Harmony Biosciences will offset losses from the drop in Harmony Biosciences' long position.
The idea behind Entero Therapeutics, and Harmony Biosciences Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Commodity Directory
Find actively traded commodities issued by global exchanges